Evonik

DHA and EPA rich algal oil JV to reach commercial stage in 2019

01-Feb-2018 By Jane Byrne

DSM and Evonik said that construction of their joint venture US$200m omega-3 fatty acid manufacturing facility at the Evonik site in Nebraska, US is underway and is proceeding according to plan.

Evonik expects lower methionine volumes in Q3

04-Aug-2017 By Jane Byrne

In its Q2 financial results, Evonik reported good demand and improved market sentiment in its animal nutrition business towards the end of the quarter. 

Nebraska site picked for Evonik, Royal DSM omega-3 joint venture

23-Jun-2017 By Aerin Einstein-Curtis

Evonik and DSM have selected a site in Blair, Nebraska to construct a $200m production facility for omega-3 generating algae.

Evonik’s Asian strategy: We will build on what Norel established

14-Mar-2017 By Jane Byrne

Evonik says it is aiming to expand its probiotics portfolio in Asia with Ecobiol, using VIV Asia as a platform.

Methionine price declines to level out: Evonik

03-Mar-2017 By Jane Byrne

Evonik said lower prices in its animal nutrition business was one of the main reason for a 13% drop in fourth quarter earnings in 2016.

Special edition: Asia Pacific Feed Developments

Evonik tracking Chinese agtech and animal nutrition innovation

06-Feb-2017 By Jane Byrne

Evonik says it is boosting its corporate venturing activities in Asia by taking a stake in a Chinese investment fund that focuses on the agriculture and nutrition sector.

Evonik underlines probiotic ambitions with IPPE launch

31-Jan-2017 By Jane Byrne

Evonik is unveiling its first in-house developed probiotic product at the IPPE trade show in Atlanta this week.

Evonik expects a subdued market environment and a decline in 2016 earnings

04-Mar-2016 By Jane Byrne

The German group, in releasing its financial results for Q4 and the full year 2015 yesterday, predicted adjusted earnings for this year could dip by as much as 19%.